Support for Physical Activity in Everyday Life With Parkinson's Disease
NCT05510739, Not applicable, Completed, Stiftelsen Stockholms Sjukhem
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Support for Physical Activity in Everyday Life With Parkinson's Disease | ClinicalTrials.gov |
| NCT number | NCT05510739 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 138 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Stiftelsen Stockholms Sjukhem | ClinicalTrials.gov |
| Conditions | Parkinson Disease, Physical Activity, eHealth, Gait Disorders, Neurologic | ClinicalTrials.gov |
| Interventions | Motor-cognitive home exercise supported by eHealth technology, Individualized home exercise program | ClinicalTrials.gov |
| First posted | 2022-08-22 | ClinicalTrials.gov |
| Last updated | 2026-07-02 | ClinicalTrials.gov |
Registered outcomes 14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | The six minute walk test | Change in balance performance at 10 weeks | This test measures walking capacity by measuring the distance covered (meters) over a time period of 6 minutes. | ClinicalTrials.gov |
| Secondary | Gait parameters during single and dual-task conditions | Change at 10 weeks | Stride length (meters); Cadence (steps/ minute) will be captured using born-worn inertial sensors | ClinicalTrials.gov |
| Secondary | Quality of life questionnaires | Change at 10 weeks and one year post-intervention | PDQ-39 is disease specific quality of life questionnaire. Items are grouped into eight scales that are scored by expressing summed item scores as a percentage score ranging between 0 and 100 | ClinicalTrials.gov |
| Secondary | Physical activity measured with accelerometers | Change at 10 weeks and one year post-intervention | Steps per day and time (minutes) in different physical activity intensities (high,moderate and low intensity) | ClinicalTrials.gov |
| Secondary | Dual-task ability during walking | Change at 10 weeks | Captured using the Auditory Stroop test during walking and expressed as percentage error of the task | ClinicalTrials.gov |
| Secondary | Balance ability | Change at 10 weeks | MiniBest test. Scoring 0-28, lower scores = greater balance impairment | ClinicalTrials.gov |
| Secondary | Executive function | Change at 10 weeks | Trail making test A \& B. Expressed as time required to perform the test (seconds) | ClinicalTrials.gov |
| Secondary | Balance Confidence | Change at 10 weeks and one year post-intervention | The Activities-specific Balance Confidence scale is a measure of confidence performing in various activities without losing balance or experiencing unsteadiness. A 16-item self-report measure with items rated on a rating scale that ranges from 0-100. A higher score indicates higher balance confidence. | ClinicalTrials.gov |
| Secondary | Health-related Quality of Life | Change at 10 weeks and one year post-intervention | The EQ-5D is a two-part instrument that measures health-related quality of life. It examines 5 domains of quality of life: mobility, self-care, daily activities, pain, anxiety/depression. It comprises 5 questions and a visual scale. | ClinicalTrials.gov |
| Secondary | Exercise Self-Efficacy | Change at 10 weeks and one year post-intervention | The Exercise Self-Efficacy Scale is an instrument examining confidence regarding carrying out regular physical activities and exercise. Questions are answered on a 4-point rating scale. A higher score indicates greater confidence. | ClinicalTrials.gov |
| Secondary | Walking ability | Change at 10 weeks and one year post-intervention | The Walk-12 questionnaire examines limitations in walking ability. It consists of 12 questions answered on either a 3-point or 5-point rating scale. | ClinicalTrials.gov |
| Secondary | Hospital Anxiety and Depression Scale | Change at 10 weeks and one year post-intervention | A 14-item measure designed to reflect the state of generalised anxiety and depression. The respondent rates each item on a 4-point scale. Higher scores indicate greater levels of anxiety or depression. | ClinicalTrials.gov |
| Secondary | Life Space Assessment | Change at 10 weeks and one year post-intervention in only the final cohort of participants | The LSA is a self-report measure of the frequency of independent mobility across 5 life-space levels. Higher scores indicate more life-space and movement throughout the community. | ClinicalTrials.gov |
| Secondary | Global Positioning System | Change at 10 weeks and one year post-intervention in only the final cohort of participants | GPS monitors collecting participant daily location and movement data via latitude and longitude coordinates collected throughout waking hours. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 37794320 | RESULT | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)